Insulin aspart, recombinant Subcutaneous and Lorazepam Concentrate
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Lorazepam Concentrate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: lorazepam
Brand name: Ativan, Lorazepam Intensol
Synonyms: Lorazepam, LORazepam
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Lorazepam injection
- Insulin aspart, recombinant Subcutaneous-Lorazepam Injection Solution
- Insulin aspart, recombinant Subcutaneous-Lorazepam Intensol
- Insulin aspart, recombinant Subcutaneous-Lorazepam Oral Concentrate
- Insulin aspart, recombinant Subcutaneous-Lorazepam Oral Solution
- Insulin aspart, recombinant Subcutaneous-Lorazepam Tablets
- Lorazepam Concentrate-Insulin degludec
- Lorazepam Concentrate-Insulin Degludec (U-100) Prefilled Pens
- Lorazepam Concentrate-Insulin Degludec (U-100) Vials
- Lorazepam Concentrate-Insulin Degludec (U-200) Prefilled Pens
- Lorazepam Concentrate-Insulin degludec and liraglutide
- Lorazepam Concentrate-Insulin degludec and liraglutide Subcutaneous